A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors

详细信息    查看全文

• 作者：James Spicer ; Sheeba Irshad ; Joo Ern Ang…
• 关键词：Afatinib ; Paclitaxel ; Bevacizumab ; Phase I ; Solid tumors
• 刊名：Cancer Chemotherapy and Pharmacology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：79
• 期：1
• 页码：17-27
• 全文大小：627KB
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Oncology; Pharmacology/Toxicology; Cancer Research;
• 出版者：Springer Berlin Heidelberg
• ISSN：1432-0843
• 卷排序：79

文摘

PurposeThe combination of afatinib, an irreversible ErbB family blocker, with paclitaxel and bevacizumab was assessed in patients with advanced solid tumors.